Related Experiment Video

Updated: Jul 4, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Management of chronic hepatitis C virus infection in HIV-infected patients

Stanislas Pol1, Vincent Soriano

  • 1Liver Unit, Université Paris Descartes, Hôpital Cochin, Paris, France. stanislas.pol@cch.aphp.fr

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 3, 2008
PubMed

Insights

Managing chronic hepatitis C virus (HCV) in patients with human immunodeficiency virus (HIV) is complex. Treatment success depends on patient factors and early response to pegylated interferon-alpha and ribavirin therapy.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Hepatitis C virus (HCV) coinfection in human immunodeficiency virus (HIV)-positive individuals presents unique management challenges.
  • Accelerated liver disease progression, immunodeficiency, and antiretroviral drug hepatotoxicity are significant concerns.

Purpose of the Study:

  • To evaluate the efficacy and challenges of treating chronic hepatitis C virus infection in patients coinfected with HIV.
  • To identify key factors influencing treatment outcomes in this population.

Main Methods:

  • Analysis of data from 5 randomized clinical trials involving coinfected patients treated with pegylated interferon-alpha and ribavirin.
  • Assessment of sustained virologic response (SVR) rates and predictors of treatment success.

Main Results:

  • Sustained virologic response rates ranged from 27% to 55% in coinfected patients receiving therapy.
  • Early virologic response was confirmed as a critical predictor of treatment outcome.
  • A considerable proportion of patients experienced hematologic tolerability issues.

Conclusions:

  • Effective management strategies for HCV/HIV coinfection require consideration of both patient-specific and viral factors.
  • Improving long-term outcomes necessitates tailored approaches to optimize treatment efficacy and manage adverse events.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...